Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new recommendations for the use of RSV vaccines in the upcoming respiratory ...

The CDC's vaccine advisory committee said it will study the childhood immunization schedule in the first meeting featuring HHS Secretary RFK Jr.'s hand-selected members.

The CDC director typically signs off on the panel's recommendations before they are implemented, but the agency does not currently have one.

The CDC plans to publish clinical considerations that outline the chronic medical conditions and other risk factors for severe RSV disease to be used under this recommendation.

The Centers for Disease Control and Prevention's vaccine advisory committee voted on Thursday to recommend infants receive a newer monoclonal antibody shot for respiratory syncytial virus (RSV ...

Business RSV vaccine access expanded to some people in their 50s, according to CDC website Automated narration. Learn more ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s Enflonsia.

Moderna rises as CDC expands RSV vaccine guidance to include high-risk adults aged 50-59, boosting mResvia's reach.